Next Article in Journal
Diabetic Corneal Neuropathy
Next Article in Special Issue
Relationship between Standard Uptake Values of Positron Emission Tomography/Computed Tomography and Salivary Metabolites in Oral Cancer: A Pilot Study
Previous Article in Journal
Incidence and Management of Hypertriglyceridemia-Associated Acute Pancreatitis: A Prospective Case Series in a Single Australian Tertiary Centre
Open AccessArticle

Serum Metabolomic Profiling of Patients with Non-Infectious Uveitis

1
Department of Ophthalmology, Tokyo Medical University, Tokyo 160-0023, Japan
2
Health Promotion and Preemptive Medicine, Research and Development Center for Minimally Invasive Therapies, Institute of Medical Sciences, Tokyo Medical University, Tokyo 160-8402, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(12), 3955; https://doi.org/10.3390/jcm9123955
Received: 30 September 2020 / Revised: 2 December 2020 / Accepted: 3 December 2020 / Published: 6 December 2020
(This article belongs to the Special Issue Metabolomic Analysis in Health and Disease)
The activities of various metabolic pathways can influence the pathogeneses of autoimmune diseases, and intrinsic metabolites can potentially be used to diagnose diseases. However, the metabolomic analysis of patients with uveitis has not yet been conducted. Here, we profiled the serum metabolomes of patients with three major forms of uveitis (Behҫet’s disease (BD), sarcoidosis, and Vogt-Koyanagi-Harada disease (VKH)) to identify potential biomarkers. This study included 19 BD, 20 sarcoidosis, and 15 VKH patients alongside 16 healthy control subjects. The metabolite concentrations in their sera were quantified using liquid chromatography with time-of-flight mass spectrometry. The discriminative abilities of quantified metabolites were evaluated by four comparisons: control vs. three diseases, and each disease vs. the other two diseases (such as sarcoidosis vs. BD + VKH). Among 78 quantified metabolites, 24 kinds of metabolites showed significant differences in these comparisons. Four multiple logistic regression models were developed and validated. The area under the receiver operating characteristic (ROC) curve (AUC) in the model to discriminate disease groups from control was 0.72. The AUC of the other models to discriminate sarcoidosis, BD, and VKH from the other two diseases were 0.84, 0.83, and 0.73, respectively. This study provides potential diagnostic abilities of sarcoidosis, BD, and VKH using routinely available serum samples that can be collected with minimal invasiveness. View Full-Text
Keywords: Behҫet’s disease; sarcoidosis; Vogt-Koyanagi-Harada disease; metabolomics; liquid chromatography-mass spectrometry; biomarker; serum Behҫet’s disease; sarcoidosis; Vogt-Koyanagi-Harada disease; metabolomics; liquid chromatography-mass spectrometry; biomarker; serum
Show Figures

Figure 1

MDPI and ACS Style

Shimizu, H.; Usui, Y.; Asakage, M.; Nezu, N.; Wakita, R.; Tsubota, K.; Sugimoto, M.; Goto, H. Serum Metabolomic Profiling of Patients with Non-Infectious Uveitis. J. Clin. Med. 2020, 9, 3955. https://doi.org/10.3390/jcm9123955

AMA Style

Shimizu H, Usui Y, Asakage M, Nezu N, Wakita R, Tsubota K, Sugimoto M, Goto H. Serum Metabolomic Profiling of Patients with Non-Infectious Uveitis. Journal of Clinical Medicine. 2020; 9(12):3955. https://doi.org/10.3390/jcm9123955

Chicago/Turabian Style

Shimizu, Hiroyuki; Usui, Yoshihiko; Asakage, Masaki; Nezu, Naoya; Wakita, Ryo; Tsubota, Kinya; Sugimoto, Masahiro; Goto, Hiroshi. 2020. "Serum Metabolomic Profiling of Patients with Non-Infectious Uveitis" J. Clin. Med. 9, no. 12: 3955. https://doi.org/10.3390/jcm9123955

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop